These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 21447053

  • 1. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J, Hag H, Jungck D, Urban K, Koch A.
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J, Sibbing B, Jungck D, Lin Y, Urban K, Stoelben E, Strauch J, Koch A.
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ.
    Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
    [Abstract] [Full Text] [Related]

  • 8. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.
    Chana KK, Fenwick PS, Nicholson AG, Barnes PJ, Donnelly LE.
    J Allergy Clin Immunol; 2014 Jan; 133(1):207-16.e1-11. PubMed ID: 24176116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
    Lea S, Plumb J, Metcalfe H, Spicer D, Woodman P, Fox JC, Singh D.
    Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
    [Abstract] [Full Text] [Related]

  • 12. [Effect of invigorating lung and kidney prescription and its components on secretion of cytokines induced by CSE and LPS].
    Wu YS, Chen YL, Li JS, Liu XF, Hao LL, Tian YG, Li Y.
    Zhong Yao Cai; 2013 Jun; 36(6):961-6. PubMed ID: 24380286
    [Abstract] [Full Text] [Related]

  • 13. [Activation of transcription factors and induction of cytokines from macrophages in chronic obstructive pulmonary disease].
    He B, Zhao M, Qi G.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 25; 81(22):1360-4. PubMed ID: 11930628
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ.
    Am J Respir Crit Care Med; 2003 Jan 01; 167(1):24-31. PubMed ID: 12406856
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages.
    Lea SR, Reynolds SL, Kaur M, Simpson KD, Hall SR, Hessel EM, Singh D.
    Int J Chron Obstruct Pulmon Dis; 2018 Jan 01; 13():771-780. PubMed ID: 29535517
    [Abstract] [Full Text] [Related]

  • 18. Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts.
    Lu Y, Liu Y, Fukuda K, Nakamura Y, Kumagai N, Nishida T.
    Invest Ophthalmol Vis Sci; 2006 Sep 01; 47(9):3796-800. PubMed ID: 16936090
    [Abstract] [Full Text] [Related]

  • 19. Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease.
    Milara J, Lluch J, Almudever P, Freire J, Xiaozhong Q, Cortijo J.
    J Allergy Clin Immunol; 2014 Aug 01; 134(2):314-22. PubMed ID: 24636089
    [Abstract] [Full Text] [Related]

  • 20. Effect of lipoteichoic acid on IL-2 and IL-5 release from T lymphocytes in asthma and COPD.
    Mat Z, Grensemann B, Yakin Y, Knobloch J, Koch A.
    Int Immunopharmacol; 2012 Jul 01; 13(3):284-91. PubMed ID: 22542695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.